ScreenCell® logo
Request a Quote

Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy

  • Lung cancer
  • By : Simona Coco, Angela Alama, Irene Vanni, Vincenzo Fontana, Carlo Genova, Maria Giovanna Dal Bello, Anna Truini, Erika Rijavec, Federica Biello, Claudio Sini, Giovanni Burrafato, Claudia Maggioni, Giulia Barletta, Francesco Grossi

DOI : 

PMID :

  • 28492516
Download the article

Abstract

Non disponibles.

Keywords

  • liquid biopsy, circulating free DNA, circulating tumor cells, non-small cell lung cancer (NSCLC), biomarkers, chemotherapy

Share on

Navigation

Quel kit correspond à mon application ?

The latest articles.

Circulating Tumor Cells from Surgical Manipulation Predict Recurrence and Poor Prognosis in Non-Small Cell Lung Cancer

  • Akikazu Kawase, Keigo Sekihara, Noriyuki Matsutani, Masafumi Yamaguchi, Yujin Kudo, Makoto Endo, Tetsukan Woo, Yuichi Saito, Noriyoshi Sawabata
  • DOI : 10.3390/jcm14062070

Optimum diagnostic pathway and pathologic confirmation rate of early stage lung cancer: Results from the VIOLET randomised controlled trial

  • Rosie A Harris, Elizabeth A Stokes, Tim J P Batchelor, Eveline Internullo, Doug West, Simon Jordan, Andrew G Nicholson, Ian Paul, Charlotte Jacobs, Michael Shackcloth, Sarah Feeney, Vladimir Anikin, Niall McGonigle, Richard Steyn, Maninder Kalkat, Dionisios Stavroulias, May Havinden Williams, Syed Qadri, Karen Dobbs, Vipin Zamvar, Lucy Macdonald, Surinder Kaur, Chris A Rogers, Eric Lim; VIOLET trialists
  • DOI : 10.1016/j.lungcan.2024.108070

Rapid separation of mononuclear hodgkin from multinuclear reed-sternberg cells

  • Narisorn Kongruttanachok, Yvon E Cayre, Hans Knecht, Sabine Mai
  • DOI : 10.1532/LH96.12023
Liquid biopsy for
enhancing patient care
through reliable CTC analysis
Request a quote
Request the brochure